Baystreet Staff - Thursday, March 23, 2017 Cancer Genetics (CGIX) Rockets Despite Quarterly Loss Cancer Genetics Inc (NASDAQ: CGIX) rose 18.1% to $3.42 after the company posted a narrower-than-expected quarterly loss. Share volume totaled 1.9 million, far better than an all-day average of 228,000